New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients

Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients

by Cleveland ClinicCredit: Pixabay/CC0 Public DomainAntibiotics routinely used in ovarian cancer care indiscriminately kill gut bacteria, leading to faster cancer progression and lower survival r
Oncology January 30,2024
Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients

Restoring the gut biome after antibiotics could lead to better outcomes for ovarian cancer patients

by Cleveland ClinicCredit: Pixabay/CC0 Public DomainAntibiotics routinely used in ovarian cancer care indiscriminately kill gut bacteria, leading to faster cancer progression and lower survival r
Oncology January 30,2024
Research perspective: Cancer prevention with rapamycin

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t
Oncology January 30,2024
Research perspective: Cancer prevention with rapamycin

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t
Oncology January 30,2024
Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

by Fred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainOver the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred H
Oncology January 30,2024
Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

by Fred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainOver the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred H
Oncology January 30,2024
Researchers discuss reassessing COVID-19 precautions in 2023

Researchers discuss reassessing COVID-19 precautions in 2023

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published inOncotarget
Oncology January 30,2024
Researchers discuss reassessing COVID-19 precautions in 2023

Researchers discuss reassessing COVID-19 precautions in 2023

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper titled "Reassessing the risks and benefits of COVID-19 precautions in 2023" has been published inOncotarget
Oncology January 30,2024
Heart disease prevention is particularly important in cancer patients

Heart disease prevention is particularly important in cancer patients

by Johannes Angerer,Medical University of ViennaBaseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-relate
Oncology January 30,2024
Heart disease prevention is particularly important in cancer patients

Heart disease prevention is particularly important in cancer patients

by Johannes Angerer,Medical University of ViennaBaseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-relate
Oncology January 30,2024
Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance
Oncology January 30,2024
Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance
Oncology January 30,2024
Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

by Nationwide Children's HospitalGraphical abstract. Credit:NAR Cancer(2023). DOI: 10.1093/narcan/zcad028In a paper published inNAR Cancer, researchers from the Center for C
Oncology January 30,2024
Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

by Nationwide Children's HospitalGraphical abstract. Credit:NAR Cancer(2023). DOI: 10.1093/narcan/zcad028In a paper published inNAR Cancer, researchers from the Center for C
Oncology January 30,2024
A potentially novel approach to improving the efficacy of natural killer cell therapies

A potentially novel approach to improving the efficacy of natural killer cell therapies

by Ludwig Cancer ResearchGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.03.030Natural killer (NK) cells have lately become a hot focus of efforts to develop new immun
Oncology January 30,2024
A potentially novel approach to improving the efficacy of natural killer cell therapies

A potentially novel approach to improving the efficacy of natural killer cell therapies

by Ludwig Cancer ResearchGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.03.030Natural killer (NK) cells have lately become a hot focus of efforts to develop new immun
Oncology January 30,2024
New genetic culprit suspected in the onset of pancreatic cancer

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat
Oncology January 30,2024
New genetic culprit suspected in the onset of pancreatic cancer

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat
Oncology January 30,2024
Dangers of late cervical cancer diagnosis in women of color

Dangers of late cervical cancer diagnosis in women of color

by Alex Osiadacz,Mayo ClinicCredit: Mayo Clinic News NetworkIn the past decade, nearly one-third of cervical cancer cases in the U.S. resulted in death according to the Centers for Disease Contr
Oncology January 30,2024
Dangers of late cervical cancer diagnosis in women of color

Dangers of late cervical cancer diagnosis in women of color

by Alex Osiadacz,Mayo ClinicCredit: Mayo Clinic News NetworkIn the past decade, nearly one-third of cervical cancer cases in the U.S. resulted in death according to the Centers for Disease Contr
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com